ARMISTICE CAPITAL, LLC Terns Pharmaceuticals, Inc. Transaction History

ARMISTICE CAPITAL, LLC portfolio value:

$3.53M
portfolio value

ARMISTICE CAPITAL, LLC quarter portfolio value change:

+137.50%
quarter

Terns Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +85.75% 276.98K shares 2.73M $5.89 600K
Q2 2022 share Increase 0.00% 323.01K shares 801K $2.48 323.01K